drugset / Trial / NCT00075959
Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
RandomizedFactorialDouble-blindTreatment
Summary
This study will determine if NXY-059 is safe in patients with an acute stroke caused by bleeding in the central nervous system. The primary objective was to assess the safety and tolerability of NXY-059 compared to placebo.
Timeline
- Start
- 2004-08
- Primary completion
- 2006-01
- Completion
- 2006-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DISUFENTON | Small molecule | — | Intravenous |